Figure 3From: Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma Chest CT showing disease response. Staging CT scan after 4 weeks of crizotinib treatment showing disease response with improvement in mediastinal nodal disease, lung metastases, and re-canalization of the left main bronchus.Back to article page